Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 15.31%252.54B | 8.84%303.06B | 9.92%266.66B | 13.51%977.37B | 8.45%237.31B | 11.25%219B | 18.35%278.45B | 15.49%242.61B | 1.07%861.02B | 9.55%218.82B |
Cost of revenue | 16.95%201.99B | 9.17%243.31B | 11.05%213.08B | 14.26%773.39B | 8.85%185.92B | 11.27%172.71B | 19.80%222.89B | 16.44%191.88B | 0.27%676.85B | 9.64%170.8B |
Gross profit | 9.20%50.55B | 7.52%59.74B | 5.64%53.58B | 10.76%203.98B | 7.03%51.4B | 11.14%46.29B | 12.88%55.56B | 12.04%50.72B | 4.11%184.17B | 9.24%48.02B |
Operating expense | 4.52%37.23B | 6.77%38.14B | 7.36%36.34B | 8.98%141.01B | 7.45%35.82B | 10.13%35.62B | 10.84%35.73B | 7.50%33.85B | 6.89%129.4B | 10.43%33.34B |
Staff costs | ---- | ---- | ---- | 10.71%69.5B | ---- | ---- | ---- | ---- | 6.50%62.78B | ---- |
Selling and administrative expenses | ---- | ---- | ---- | 3.48%28.73B | ---- | ---- | ---- | ---- | 6.20%27.76B | ---- |
-General and administrative expense | ---- | ---- | ---- | 3.48%28.73B | ---- | ---- | ---- | ---- | 6.20%27.76B | ---- |
Depreciation and amortization | ---- | ---- | ---- | -0.60%6.26B | ---- | ---- | ---- | ---- | 2.36%6.3B | ---- |
-Depreciation | ---- | ---- | ---- | -0.60%6.26B | ---- | ---- | ---- | ---- | 2.36%6.3B | ---- |
Rent and land expenses | ---- | ---- | ---- | -1.40%7.99B | ---- | ---- | ---- | ---- | 8.33%8.1B | ---- |
Other operating expenses | ---- | ---- | ---- | 16.67%28.54B | ---- | ---- | ---- | ---- | 9.48%24.46B | ---- |
Operating profit | 24.81%13.33B | 8.88%21.6B | 2.18%17.24B | 14.96%62.97B | 6.08%15.58B | 14.67%10.68B | 16.74%19.84B | 22.41%16.88B | -1.90%54.77B | 6.63%14.68B |
Net non-operating interest income (expenses) | 300.00%10M | 200.00%6M | 250.00%9M | 11.54%-23M | -20.00%-6M | 16.67%-5M | 14.29%-6M | 25.00%-6M | 13.33%-26M | 44.44%-5M |
Non-operating interest income | 520.00%31M | 240.00%17M | 375.00%19M | 5.88%18M | -33.33%4M | 25.00%5M | 0.00%5M | 100.00%4M | 21.43%17M | 200.00%6M |
Non-operating interest expense | 110.00%21M | 0.00%11M | 0.00%10M | -4.65%41M | -9.09%10M | 0.00%10M | -8.33%11M | 0.00%10M | -2.27%43M | 0.00%11M |
Net investment income | 2,660.00%690M | 10.84%184M | -31.43%24M | 26.19%742M | 22.57%516M | -3.85%25M | 72.92%166M | -22.22%35M | 103.46%588M | 169.87%421M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 117.19%11M | 0 | -111.91%-71M | 0 | 0 | -64M | -101.02%-7M | 3,036.84%596M | -750.00%-91M |
Income from associates and other participating interests | -27.18%225M | 31.96%128M | -16.24%294M | 24.81%825M | 223.81%68M | 70.72%309M | -39.75%97M | 17.79%351M | -16.75%661M | -78.57%21M |
Special income (charges) | 0.00%-1M | -407.14%-71M | -14M | 161.52%446M | 140.87%461M | 97.62%-1M | 6.67%-14M | 0 | -220.03%-725M | -1,384.21%-1.13B |
Less:Other special charges | 0.00%1M | --71M | --14M | -74.94%-691M | -8,925.00%-706M | -97.62%1M | ---- | ---- | 52.06%-395M | -68.00%8M |
Less:Write off | ---- | ---- | ---- | -78.13%245M | ---- | ---- | ---- | ---- | 409.09%1.12B | ---- |
Other non-operating income (expenses) | -141.20%-89M | 198.98%293M | -59.43%71M | -98.29%11M | -2,415.79%-478M | -23.40%216M | -40.24%98M | -19.72%175M | -5.70%645M | -128.79%-19M |
Income before tax | 26.20%14.16B | 10.13%22.15B | 1.17%17.63B | 14.83%64.89B | 16.26%16.13B | 15.06%11.22B | 15.63%20.11B | 12.52%17.42B | -2.89%56.51B | -0.98%13.88B |
Income tax | 28.09%4.27B | 9.63%6.76B | 2.23%5.77B | 5.03%16.8B | -51.84%1.66B | 22.77%3.33B | 23.59%6.17B | 16.44%5.64B | -9.71%16B | -11.57%3.45B |
Net income | 25.38%9.89B | 10.36%15.39B | 0.65%11.86B | 18.71%48.09B | 38.76%14.47B | 12.10%7.89B | 12.43%13.95B | 10.73%11.78B | 0.10%40.51B | 3.10%10.43B |
Net income continuous operations | 25.40%9.89B | 10.35%15.39B | 0.65%11.86B | 18.71%48.09B | 38.76%14.47B | 12.09%7.89B | 12.43%13.95B | 10.74%11.78B | 0.10%40.51B | 3.10%10.43B |
Noncontrolling interests | 12.79%194M | 14.88%139M | -5.35%177M | 31.15%640M | 8.84%160M | 16.22%172M | 63.51%121M | 57.14%187M | -10.13%488M | 34.86%147M |
Net income attributable to the company | 25.69%9.7B | 10.31%15.25B | 0.76%11.68B | 18.55%47.45B | 39.19%14.31B | 12.00%7.72B | 12.14%13.83B | 10.19%11.59B | 0.24%40.02B | 2.77%10.28B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 25.69%9.7B | 10.31%15.25B | 0.76%11.68B | 18.55%47.45B | 39.19%14.31B | 12.00%7.72B | 12.14%13.83B | 10.19%11.59B | 0.24%40.02B | 2.77%10.28B |
Gross dividend payment | ||||||||||
Basic earnings per share | 25.67%25.58 | 10.31%40.22 | 0.75%30.8 | 18.56%125.13 | 39.18%37.745 | 12.03%20.355 | 12.13%36.46 | 10.20%30.57 | 0.24%105.545 | 2.77%27.12 |
Diluted earnings per share | 25.68%25.58 | 10.31%40.2187 | 0.75%30.8 | 18.56%125.13 | 39.19%37.745 | 12.02%20.3533 | 12.14%36.46 | 10.20%30.57 | 0.24%105.545 | 2.77%27.1175 |
Dividend per share | 0 | 0 | 0 | 8.00%67.5 | 8.00%67.5 | 0 | 0 | 0 | 8.70%62.5 | 8.70%62.5 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |